Patent details
EP2203462
Title:
NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Basic Information
- Publication number:
- EP2203462
- PCT Application Number:
- US2008058183
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP087328183
- PCT Publication Number:
- WO2008121634
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
- French Title of Invention:
- PROMÉDICAMENTS DE PHOSPHORAMIDATE DE NUCLÉOSIDE
- German Title of Invention:
- NUKLEOSID-PHOSPHORAMIDAT-PRODRUGS
- SPC Number:
-
92600
Dates
- Filing date:
- 26/03/2008
- Grant date:
- 21/05/2014
- EP Publication Date:
- 07/07/2010
- PCT Publication Date:
- 09/10/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/07/2010
- EP B1 Publication Date:
- 21/05/2014
- EP B2 Publication Date:
- 25/09/2024
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/03/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/09/2024
-
-
- Name:
- Gilead Pharmasset LLC
- Address:
- Gilead Sciences, Inc.
333 Lakeside Drive, Foster City, CA 94404, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 08/07/2014
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SOFIA, Michael, Joseph
- Address:
- United States (US)
2
- Name:
- DU, Jinfa
- Address:
- United States (US)
3
- Name:
- NAGARATHNAM, Dhanapalan
- Address:
- United States (US)
4
- Name:
- WANG, Peiyuan
- Address:
- United States (US)
Priority
1
- Priority Number:
- 909315 P
- Priority Date:
- 30/03/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 982309 P
- Priority Date:
- 24/10/2007
- Priority Country:
- United States (US)
3
- Priority Number:
- 53015
- Priority Date:
- 21/03/2008
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/7064;
A61K 31/7076;
Publication
European Patent Bulletin
- Issue number:
- 202439
- Publication date:
- 25/09/2024
- Description:
- Patent maintained (B2 publication)
Annual Fees
- Annual Fee Due Date:
- 31/03/2026
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 13/03/2025
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM